Filing Details

Accession Number:
0001708138-21-000049
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-10 17:54:25
Reporting Period:
2021-08-09
Accepted Time:
2021-08-10 17:54:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1411984 P Daniel Plew Van 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp & General Mgr, Industrial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-09 25,000 $270.43 51,931 No 4 M Direct
Common Stock Disposition 2021-08-09 18,397 $617.68 33,534 No 4 F Direct
Common Stock Disposition 2021-08-10 244 $606.50 33,290 No 4 S Direct
Common Stock Disposition 2021-08-10 762 $607.21 32,528 No 4 S Direct
Common Stock Disposition 2021-08-10 697 $608.50 31,831 No 4 S Direct
Common Stock Disposition 2021-08-10 200 $609.25 31,631 No 4 S Direct
Common Stock Disposition 2021-08-10 100 $610.81 31,531 No 4 S Direct
Common Stock Disposition 2021-08-10 400 $611.57 31,131 No 4 S Direct
Common Stock Disposition 2021-08-10 900 $612.45 30,231 No 4 S Direct
Common Stock Disposition 2021-08-10 1,600 $613.34 28,631 No 4 S Direct
Common Stock Disposition 2021-08-10 1,120 $614.33 27,511 No 4 S Direct
Common Stock Disposition 2021-08-10 280 $615.22 27,231 No 4 S Direct
Common Stock Disposition 2021-08-10 300 $616.27 26,931 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-08-09 25,000 $0.00 25,000 $270.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2023-12-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,048 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 244 shares of Company stock on August 10, 2021 at prices ranging from $606.32 to $606.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  2. Represents volume-weighted average price of sales of 762 shares of Company stock on August 10, 2021 at prices ranging from $607.00 to $607.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  3. Represents volume-weighted average price of sales of 697 shares of Company stock on August 10, 2021 at prices ranging from $608.17 to $608.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  4. Represents volume-weighted average price of sales of 200 shares of Company stock on August 10, 2021 at prices ranging from $609.21 to $609.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  5. Represents volume-weighted average price of sales of 400 shares of Company stock on August 10, 2021 at prices ranging from $611.22 to $611.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  6. Represents volume-weighted average price of sales of 900 shares of Company stock on August 10, 2021 at prices ranging from $612.03 to $612.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  7. Represents volume-weighted average price of sales of 1,600 shares of Company stock on August 10, 2021 at prices ranging from $613.07 to $613.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  8. Represents volume-weighted average price of sales of 1,120 shares of Company stock on August 10, 2021 at prices ranging from $614.08 to $614.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  9. Represents volume-weighted average price of sales of 280 shares of Company stock on August 10, 2021 at prices ranging from $615.00 to $615.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  10. Represents volume-weighted average price of sales of 300 shares of Company stock on August 10, 2021 at prices ranging from $616.01 to $616.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
  11. The stock option award vests in four equal annual installments, commencing one year after the date of grant.